This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXNPEC0L0PD_M.jpg
Orbimed Capital’s holding in Arcutis Biotherapeutics, Inc. increased to about 902 thousand shares with the purchase.
Orbimed Capital increased stake in Arcutis Biotherapeutics, Inc.
4 years ago
No Comments
Related Posts
Australia stocks higher at close of trade; S&P/ASX 200 up 0.46%
December 13, 2019
U.S. Securities and Exchange Commission 'actively monitoring' volatility in equity markets
January 27, 2021
Cash in your pocket: this week’s biggest dividend hikes
November 12, 2022
Factbox-LVMH roles held by Bernard Arnault’s children
January 11, 2023
U.S. SEC sues Mylan for concealing possible loss tied to EpiPen
September 27, 2019
Audi of America pauses paid Twitter advertising
November 3, 2022
About The Author
